Compounds > cyclohexanol

Page last updated: 2024-08-18

cyclohexanol and canventol

cyclohexanol has been researched along with canventol in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	6 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fujiki, H; Komori, A; Ohta, T; Okabe, S; Sueoka, E; Suganuma, M; Yatsunami, J	1
Fujiki, H; Komori, A; Okabe, S; Suganuma, M; Tius, MA; Zou, X	1
Biswas, DK; Pardee, AB; Tius, MA; Zhuo, J	1
Fujiki, H; Iida, N; Kim, SJ; Komori, A; Okabe, S; Sueoka, E; Suganuma, M	1
Busch-Petersen, J; Fujiki, H; Kannangara, GS; Kerr, MA; Komori, A; Oh, LM; Okabe, S; Suganuma, M; Tius, MA; Zhuo, J; Zou, X	1
Biswas, DK; Ewaniuk, DS; Kannangara, GS; Mhashilkar, AM; Oh, LM; Pardee, AB; Pezza, JA; Tius, MA	1

Reviews

1 review(s) available for cyclohexanol and canventol

Article	Year
A new tumor promotion pathway and its inhibitors. Cancer detection and prevention, 1994, Volume: 18, Issue:1 Topics: Anticarcinogenic Agents; Catechin; Cyclohexanols; Diterpenes; Ethers, Cyclic; Humans; Neoplasms; Okadaic Acid; Tumor Necrosis Factor-alpha	1994

Other Studies

5 other study(ies) available for cyclohexanol and canventol

Article	Year
Canventol inhibits tumor promotion in CD-1 mouse skin through inhibition of tumor necrosis factor alpha release and of protein isoprenylation. Cancer research, 1993, Aug-01, Volume: 53, Issue:15 Topics: 3T3 Cells; 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Cyclohexanols; Diterpenes; Ethers, Cyclic; Female; Mevalonic Acid; Mice; Okadaic Acid; Protein Prenylation; Skin Neoplasms; Tumor Necrosis Factor-alpha	1993
Canventol inhibits HIV-1 replication by Tat-induced Tar-independent mechanism. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1996, Jun-01, Volume: 12, Issue:2 Topics: Antiviral Agents; Base Sequence; Benzodiazepines; Cell Line; Cyclohexanols; Down-Regulation; Drug Synergism; Gene Products, tat; HIV Long Terminal Repeat; HIV-1; Humans; Molecular Sequence Data; NF-kappa B; Oligodeoxyribonucleotides; Promoter Regions, Genetic; Pyrroles; tat Gene Products, Human Immunodeficiency Virus; Transcriptional Activation; Tumor Necrosis Factor-alpha; Virus Replication	1996
A new process of cancer prevention mediated through inhibition of tumor necrosis factor alpha expression. Cancer research, 1996, Aug-15, Volume: 56, Issue:16 Topics: 3T3 Cells; Animals; Anticarcinogenic Agents; Base Sequence; Catechin; Cyclohexanols; Diterpenes; Humans; Mice; Molecular Sequence Data; Proto-Oncogenes; Tamoxifen; Tumor Necrosis Factor-alpha	1996
Anti-tumor promoting activity of canventol and its synthetic analogs through inhibition of protein isoprenylation. Japanese journal of cancer research : Gann, 1996, Volume: 87, Issue:9 Topics: 3T3 Cells; Alkyl and Aryl Transferases; Animals; Anticarcinogenic Agents; Carcinogens; Cyclohexanols; Enzyme Inhibitors; Female; Lipid Metabolism; Mevalonic Acid; Mice; Mice, Inbred Strains; Okadaic Acid; Protein Prenylation; Skin Neoplasms; Sterols; Transferases; Ubiquinone	1996
Inhibition of HIV-1 replication by combination of a novel inhibitor of TNF-alpha with AZT. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1998, Aug-15, Volume: 18, Issue:5 Topics: Anti-HIV Agents; Anticarcinogenic Agents; Antineoplastic Agents; CD4-Positive T-Lymphocytes; Cell Line; Cyclohexanols; Diterpenes; Drug Combinations; Drug Synergism; Gene Products, tat; HIV-1; Humans; Jurkat Cells; NF-kappa B; Repetitive Sequences, Nucleic Acid; Reverse Transcriptase Inhibitors; tat Gene Products, Human Immunodeficiency Virus; Transfection; Tumor Necrosis Factor-alpha; Virus Replication; Zidovudine	1998